UGRP1 Antibodies

Santa Cruz Biotechnology offers a broad range of UGRP1 monoclonal antibodies for research focused on understanding UGRP1's role in various biological processes. UGRP1 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). UGRP1, or Urothelial Glycoprotein 1, plays a significant role in cellular signaling and has been implicated in various physiological and pathological processes, including cancer progression and inflammation. Expression patterns and functional implications make UGRP1 a key target for research aimed at understanding disease mechanisms and developing therapeutic strategies. The study of UGRP1 continues to reveal important insights in fields such as oncology and urology. Researchers can utilize UGRP1 monoclonal antibodies to explore cellular pathways and molecular mechanisms. Advanced detection methods, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates, enable precise visualization and quantification of UGRP1. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of UGRP1's role in health and disease.